Pro Medicus Limited (ASX:PME – Get Free Report) insider Anthony Hall bought 2,250 shares of the company’s stock in a transaction dated Monday, December 22nd. The shares were acquired at an average price of A$221.90 per share, for a total transaction of A$499,275.00.
Anthony Hall also recently made the following trade(s):
- On Tuesday, December 23rd, Anthony Hall purchased 2,270 shares of Pro Medicus stock. The stock was acquired at an average cost of A$220.31 per share, with a total value of A$500,103.70.
Pro Medicus Stock Performance
The company has a debt-to-equity ratio of 1.10, a current ratio of 5.98 and a quick ratio of 4.39. The stock has a market capitalization of $29.16 billion, a PE ratio of 351.99, a P/E/G ratio of 3.87 and a beta of 0.56.
Pro Medicus Company Profile
Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products.
Further Reading
- Five stocks we like better than Pro Medicus
- The boring AI play that could pay up to $4,290 monthly
- Trump’s “real estate deal for America” explained
- A month before the crash
- Put $1,000 into this stock by Jan 1 [Not NVDA]
- Trump Did WHAT??
Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.
